Ignite Creation Date:
2024-05-05 @ 4:56 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00343291
Status:
COMPLETED
Last Update Posted:
2011-06-07
First Post:
2006-06-20
Brief Title:
A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIbIV NSCLC
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company